General experimental information
Column chromatography was carried out with SiO2 60 (particle size 0.040-0.063 mm, 230-400 mesh; Merck) and commercially available solvents. Thin layer chromatography (TLC) was conducted on aluminium sheets coated with SiO2 60 F254 obtained from Merck, with visualisation by UV lamp (254 or 360 nm). Melting points (mp) were measured on a Büchi B-540 melting-point apparatus in open capillaries and are uncorrected.
1 H-and 13 C-NMR spectra were recorder at 360/400/500 MHz and 90/100/125 MHz, respectively, with Bruker AMX 360, Avance 400 or Avance 500 instruments at 25°C. Chemical shifts are reported in ppm relative to TMS.
Residual solvent signals in the 1 H-and 13 C-NMR spectra were used as an internal reference 
General synthesis of imidazole derivatives 15a-d
A solution of α-bromoketone 14a-d (0.5 mmol) in CH2Cl2 (10 mL) was added dropwise to a solution of 1H-imidazole (170 mg, 2.5 mmol) in DMF/THF 5:1 (10 mL) and the reaction mixture was stirred 2-4 hours at 0°C. The reaction mixture was poured onto 300 mL of water and the product was extracted with CH2Cl2 (3×50 mL). DMF and excess of 1H-imidazole were removed by repeated washing of the combined organic layers with water (5×100 mL). The combined organic layers were dried (Na2SO4) and the solvents were evaporated. The crude product was purified by column chromatography (SiO2; hexane/EtOAc/MeOH/NH4OH, 3:5:1:0.1)
(S)-Benzyl [4-(1H-imidazol-1-yl)-3-oxobutan-2-yl]carbamate (15a)
White solid. [α]D 20 -0.7 (c 1, MeOH).
Crystallography: Slow crystallization from THF provided crystals suitable for X-Ray measurement (see below). 
H NMR

ESI-MS: m/z
Benzyl [(3S,4S)-1-(1H-imidazol-1-yl)-4-methyl-2-oxohexan-3-yl]carbamate (15d)
Yellowish oil. 
Rf
Crystallography
The X-ray measurements were carried out on a Bruker Kappa CCD diffractometer equipped with Figure S2 . 1 H NMR spectrum of derivative 15a (d6-acetone, 500 MHz). 
